{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:21Z","timestamp":1787020161870,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID) continues to be a major public-health burden in this highly stigmatised population. To halt transmission of HCV, rapid HCV self-testing kits represent an innovative approach that could enable PWID to know their HCV status and seek treatment. As no HCV test has yet been licenced for self-administration, it is crucial to obtain knowledge around the factors that may deter or foster delivery of HCV self-testing among PWID in resource-constrained countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A qualitative study to assess values and preferences relating to HCV self-testing was conducted in mid-2020 among PWID in the Bishkek and Chui regions of Kyrgyzstan. Forty-seven PWID participated in 15 individual interviews, two group interviews (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) and one participatory action-research session (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920). Responses were analysed using a thematic analysis approach with 4 predefined themes: awareness of HCV and current HCV testing experiences, and acceptability and service delivery preferences for HCV self-testing. Informants\u2019 insights were analysed using a thematic analysis approach. This research received local ethics approval.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Awareness of HCV is low and currently PWID prefer community-based HCV testing due to stigma encountered in other healthcare settings. HCV self-testing would be accepted and appreciated by PWID. Acceptability may increase if HCV self-testing: was delivered in pharmacies or by harm reduction associations; was free of charge; was oral rather than blood-based; included instructions with images and clear information on the test\u2019s accuracy; and was distributed alongside pre- and post-testing counselling with linkage to confirmatory testing support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HCV self-testing could increase awareness of and more frequent testing for HCV infection among PWID in Kyrgyzstan. It is recommended that peer-driven associations are involved in the delivery of any HCV self-testing. Furthermore, efforts should be maximised to end discrimination against PWID at the healthcare institutions responsible for confirmatory HCV testing and treatment provision.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06332-z","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T20:02:23Z","timestamp":1624651343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan"],"prefix":"10.1186","volume":"21","author":[{"given":"Guillermo Z.","family":"Mart\u00ednez-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danil S.","family":"Nikitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Bessonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Bessonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonjelle","family":"Shilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"key":"6332_CR1","volume-title":"Global hepatitis report, 2017","author":"WHO","year":"2017","unstructured":"WHO. Global hepatitis report, 2017. Geneva: WHO; 2017."},{"issue":"Suppl 2(Suppl S","key":"6332_CR2","doi-asserted-by":"publisher","first-page":"e25050","DOI":"10.1002\/jia2.25050","volume":"21","author":"YJ Hutin","year":"2018","unstructured":"Hutin YJ, Bulterys M, Hirnschall GO. How far are we from viral hepatitis elimination service coverage targets? J Int AIDS Soc. 2018;21(Suppl 2(Suppl Suppl 2)):e25050.","journal-title":"J Int AIDS Soc"},{"key":"6332_CR3","volume-title":"Global health sector strategy on viral hepatitis 2016-2021","author":"WHO","year":"2016","unstructured":"WHO. Global health sector strategy on viral hepatitis 2016-2021. Geneva: WHO; 2016."},{"issue":"4","key":"6332_CR4","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","volume":"9","author":"E Oru","year":"2021","unstructured":"Oru E, Trickey A, Shirali R, Kanters S, Easterbrook P. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Lancet Glob Health. 2021;9(4):e431\u2013e45. https:\/\/doi.org\/10.1016\/S2214-109X(20)30505-2.","journal-title":"Lancet Glob Health"},{"key":"6332_CR5","volume-title":"Progress report on access to hepatitis C treatment; Focus on overcoming barriers in low- and middle-income countries","author":"WHO","year":"2018","unstructured":"WHO. Progress report on access to hepatitis C treatment; Focus on overcoming barriers in low- and middle-income countries. Geneva: WHO; 2018."},{"issue":"1 Suppl","key":"6332_CR6","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.jhep.2016.08.002","volume":"65","author":"PJ Easterbrook","year":"2016","unstructured":"Easterbrook PJ. WHO to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries. J Hepatol. 2016;65(1 Suppl):S46\u2013s66. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.002.","journal-title":"J Hepatol"},{"key":"6332_CR7","volume-title":"Guidelines on hepatitis B and C testing","author":"WHO","year":"2017","unstructured":"WHO. Guidelines on hepatitis B and C testing. Geneva: WHO; 2017."},{"issue":"2","key":"6332_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.idc.2018.02.010","volume":"32","author":"TL Applegate","year":"2018","unstructured":"Applegate TL, Fajardo E, Sacks JA. Hepatitis C virus diagnosis and the holy grail. Infect Dis Clin N Am. 2018;32(2):425\u201345. https:\/\/doi.org\/10.1016\/j.idc.2018.02.010.","journal-title":"Infect Dis Clin N Am"},{"key":"6332_CR9","volume-title":"Hepatitis C Market Report","author":"CHAI","year":"2020","unstructured":"CHAI. Hepatitis C Market Report. 2020."},{"issue":"Suppl 1","key":"6332_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s12879-017-2775-0","volume":"17","author":"RW Peeling","year":"2017","unstructured":"Peeling RW, Boeras DI, Marinucci F, Easterbrook P. The future of viral hepatitis testing: innovations in testing technologies and approaches. BMC Infect Dis. 2017;17(Suppl 1):699. https:\/\/doi.org\/10.1186\/s12879-017-2775-0.","journal-title":"BMC Infect Dis"},{"key":"6332_CR11","volume-title":"Guidelines on HIV self-testing and partner notification - Supplement to consolidated guidelines on HIV testing services","author":"WHO","year":"2016","unstructured":"WHO. Guidelines on HIV self-testing and partner notification - Supplement to consolidated guidelines on HIV testing services. Geneva: WHO; 2016."},{"key":"6332_CR12","unstructured":"WHO. Status of HIV self-testing (HIVST) in national policies. Geneva: WHO; 2019."},{"key":"6332_CR13","doi-asserted-by":"publisher","unstructured":"Eshun-Wilson I, Jamil MS, T Charles W, Glidden DV, Cheryl J, Noelle T, Ford N, McGee K, Chris K, Stefan B, Schwartz S, Elvin GH. A systematic review and network meta-analyses to assess the effectiveness of HIV self-testing distribution strategies. Clin Infect Dis. 2021;ciab029. https:\/\/doi.org\/10.1093\/cid\/ciab029. Epub ahead of print.","DOI":"10.1093\/cid\/ciab029"},{"issue":"1","key":"6332_CR14","doi-asserted-by":"publisher","first-page":"21594","DOI":"10.7448\/IAS.20.1.21594","volume":"20","author":"CC Johnson","year":"2017","unstructured":"Johnson CC, Kennedy C, Fonner V, Siegfried N, Figueroa C, Dalal S, et al. Examining the effects of HIV self-testing compared to standard HIV testing services: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21594. https:\/\/doi.org\/10.7448\/IAS.20.1.21594.","journal-title":"J Int AIDS Soc"},{"key":"6332_CR15","doi-asserted-by":"publisher","unstructured":"Nguyen LT, Nguyen VTT, Le Ai KA, Truong MB, Tran TTM, Jamil MS, Johnson C, Reipold EI, Easterbrook P, Park K. Acceptability and Usability of HCV Self-Testing in High Risk Populations in Vietnam. Diagnostics. 2021;11(2):377. https:\/\/doi.org\/10.3390\/diagnostics11020377.","DOI":"10.3390\/diagnostics11020377"},{"issue":"1","key":"6332_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12985-020-1293-7","volume":"17","author":"L Liu","year":"2020","unstructured":"Liu L, Zhang M, Hang L, Kong F, Yan H, Zhang Y, et al. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection. Virol J. 2020;17(1):14. https:\/\/doi.org\/10.1186\/s12985-020-1293-7.","journal-title":"Virol J"},{"issue":"2","key":"6332_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.diagmicrobio.2019.05.010","volume":"95","author":"MM Kimble","year":"2019","unstructured":"Kimble MM, Stafylis C, Treut P, Saab S, Klausner JD. Clinical evaluation of a hepatitis C antibody rapid immunoassay on self-collected oral fluid specimens. Diagn Microbiol Infect Dis. 2019;95(2):149\u201351. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.05.010.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"6332_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/add.14393","volume":"114","author":"J Grebely","year":"2019","unstructured":"Grebely J, Larney S, Peacock A, Colledge S, Leung J, Hickman M, et al. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. 2019;114(1):150\u201366. https:\/\/doi.org\/10.1111\/add.14393.","journal-title":"Addiction."},{"issue":"1","key":"6332_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/liv.13949","volume":"39","author":"E Day","year":"2019","unstructured":"Day E, Hellard M, Treloar C, Bruneau J, Martin NK, \u00d8vrehus A, et al. Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework. Liver Int. 2019;39(1):20\u201330. https:\/\/doi.org\/10.1111\/liv.13949.","journal-title":"Liver Int"},{"issue":"1","key":"6332_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12954-019-0338-y","volume":"17","author":"J Enkelmann","year":"2020","unstructured":"Enkelmann J, Gassowski M, Nielsen S, Wenz B, Ro\u00df S, Marcus U, et al. High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing. Harm Reduct J. 2020;17(1):7. https:\/\/doi.org\/10.1186\/s12954-019-0338-y.","journal-title":"Harm Reduct J"},{"issue":"1","key":"6332_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12879-018-3185-7","volume":"18","author":"A Guise","year":"2018","unstructured":"Guise A, Witzel TC, Mandal S, Sabin C, Rhodes T, Nardone A, et al. A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London. UK BMC Infect Dis. 2018;18(1):281. https:\/\/doi.org\/10.1186\/s12879-018-3185-7.","journal-title":"UK BMC Infect Dis"},{"key":"6332_CR22","volume-title":"Kyrgyzstan: CGHE (Coalition for Global Hepatitis Elimination)","author":"CGHE","year":"2021","unstructured":"CGHE. Kyrgyzstan: CGHE (Coalition for Global Hepatitis Elimination); 2021 [Available from: https:\/\/www.globalhep.org\/country-progress\/kyrgyzstan"},{"key":"6332_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ijid.2020.12.068","volume":"104","author":"S Davlidova","year":"2021","unstructured":"Davlidova S, Haley-Johnson Z, Nyhan K, Farooq A, Vermund SH, Ali S. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: a systematic review. Int J Infect Dis. 2021;104:510\u201325. https:\/\/doi.org\/10.1016\/j.ijid.2020.12.068.","journal-title":"Int J Infect Dis"},{"key":"6332_CR24","volume-title":"USAID Central Asia HIV Flagship. Activity Fact Sheet: USAID","author":"USAID","year":"2021","unstructured":"USAID. USAID Central Asia HIV Flagship. Activity Fact Sheet: USAID; 2021 [Available from: https:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/06122020_USAID_Central_Asia_HIV_Flagship_Activity_Fact_Sheet.pdf."},{"key":"6332_CR25","volume-title":"Introduction to qualitative research methodology","author":"K Kielmann","year":"2011","unstructured":"Kielmann K, Cataldo F, Seeley J. Introduction to qualitative research methodology. London: DFID; 2011."},{"issue":"6","key":"6332_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"6332_CR27","volume-title":"Accelerating access to hepatitis C diagnostics and treatment; Overcoming barriers in lowand middle-income countries, Global progress report 2020","author":"WHO","year":"2021","unstructured":"WHO. Accelerating access to hepatitis C diagnostics and treatment; Overcoming barriers in lowand middle-income countries, Global progress report 2020. Geneva: WHO; 2021."},{"key":"6332_CR28","volume-title":"Self-testing for HCV: Multicountry evidence on usability and acceptability. Conference on Retroviruses and Opportunistic Infections","author":"EI Reipold","year":"2021","unstructured":"Reipold EI, Van Nguyen TT, Shiha G, Stvilia K, Monroe-Wise A, Wang C, et al. Self-testing for HCV: Multicountry evidence on usability and acceptability. Conference on Retroviruses and Opportunistic Infections; 2021; Virtual conference."},{"issue":"11","key":"6332_CR29","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s10461-015-1097-8","volume":"19","author":"C Figueroa","year":"2015","unstructured":"Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949\u201365. https:\/\/doi.org\/10.1007\/s10461-015-1097-8.","journal-title":"AIDS Behav"},{"issue":"1","key":"6332_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1186\/1471-2458-13-735","volume":"13","author":"J Krause","year":"2013","unstructured":"Krause J, Subklew-Sehume F, Kenyon C, Colebunders R. Acceptability of HIV self-testing: a systematic literature review. BMC Public Health. 2013;13(1):735. https:\/\/doi.org\/10.1186\/1471-2458-13-735.","journal-title":"BMC Public Health"},{"key":"6332_CR31","volume-title":"Partnership Network, Bishkek [Report in Russian]: ITPCRU","author":"A Sultangaziev","year":"2020","unstructured":"Sultangaziev A. Analysis of procuring ARV and HCV medications in the Kyrgyz Republic. In: Partnership Network, Bishkek [Report in Russian]: ITPCRU; 2020. [Available from: https:\/\/itpcru.org\/2020\/06\/18\/opublikovan-analiz-zakupok-arv-preparatov-i-preparatov-dlya-lecheniya-gepatita-s-v-kyrgyzstane-v-2019-godu\/ on June 02, 2021."},{"issue":"Suppl 1","key":"6332_CR32","doi-asserted-by":"publisher","first-page":"e25251","DOI":"10.1002\/jia2.25251","volume":"22","author":"MK Kumwenda","year":"2019","unstructured":"Kumwenda MK, Johnson CC, Choko AT, Lora W, Sibande W, Sakala D, et al. Exploring social harms during distribution of HIV self-testing kits using mixed-methods approaches in Malawi. J Int AIDS Soc. 2019;22(Suppl 1):e25251. https:\/\/doi.org\/10.1002\/jia2.25251.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06332-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06332-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06332-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T20:02:51Z","timestamp":1624651371000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06332-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6332"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06332-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]},"assertion":[{"value":"16 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Committee on Bioethics, under the Global Research Institute in the Kyrgyz Republic (Ref. 011082020\u20131). All informants provided written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicting or competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"609"}}